November 28, 2022
In collaboration with researchers in Wurzburg, Germany, Atuka has co-authored a new paper that further characterises the AAV-A53T-aSyn rat model of Parkinson’s disease. Atuka extensively uses this model to evaluate potential therapies for Parkinson’s disease. The full paper is available here.
Description & References:
Product Spec:
CAS No.:
Molecular Structure: